News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

JT And Torii Pharmaceutical Co. To Launch New HIV Treatment Drug In Japan


10/19/2005 5:10:43 PM

Japan Tobacco Inc. (JT) (TSE: 2914) and Torii Pharmaceutical Co., Ltd. (TSE: 4551), JT's pharmaceutical business subsidiary, announced today that the companies would launch the HIV treatment drug "Viread(R) Tab. 300mg" (generic name: Tenofovir Disoproxil Fumarate), licensed by Gilead Sciences, Inc. (Gilead) (Nasdaq: GILD), starting April 12 in Japan.

Read at JCN Newswire


comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES